
Dr. Loren K. Mell
@drlorenmell
Tenured Professor | Co-Director, Hanna & Mark Gleiberman Center | Vice Chair, Clinical & Translational Research | UC San Diego Dept. of Radiation Medicine
ID: 360338556
https://profiles.ucsd.edu/loren.mell 23-08-2011 01:57:31
477 Tweet
1,1K Followers
845 Following

At the time of post-hoc extended analysis, with a median follow-up of 2.3 years, 2-year PFS was 50.6% in the durvalumab group (95% CI, 41.5%-59.8%) and 63.7% in the cetuximab group (95% CI, 51.3%-76.1%). #hncsm | Dr. Loren K. Mell cancernetwork.com/view/durvaluma…

☢️ #ACRO2025 moderator Anna Lee shares a sneak peek at the Head & Neck session with speakers Dr. Loren K. Mell & @jessschuster! Don't forget: early bird registration ends Friday! 🐦 #ACROinVegas #AcingCancerCare


Don't miss the #ACRO2025 Head & Neck session with Dr. Loren K. Mell & @jessschuster! Register today and join us for #ACROinVegas: acro.org/annual_meeting


Announcing NRG-CC014 (PREEMPT) by Dr. Gillespie! 📢 A Phase 3 trial exploring radiation therapy for high-risk asymptomatic bone metastases. A step forward in innovative cancer care! Erin Gillespie, MD MPH #radonc NRG Oncology RTOG Foundation #NRG2025


I’d like to highlight this @ASTRO News article on ctDNA written by Scott Bratman. astro.org/news-and-publi… 1/x




Props to editors Retraction Watch for publishing my dissent about their The Atlantic article about R. F. K .Jr today retractionwatch.com Vinay Prasad MD MPH UC San Diego Health Moores Cancer Center UC San Diego Rad Med Ralph Weichselbaum Tyler Seibert MD PhD ; there’s more too will post follow up to add to story

Great conference! I really enjoyed meeting everyone and having the opportunity to present on reirradiation. Thanks ACRO - American College of Radiation Oncology for the invitation! @jessschuster




Coolest Lego kit ever! Made by a young patient of Brian Chou ! Not suitable for 100+ year olds however 🤣






Amazing work Bea Fregonese presenting our initial results on financial toxicity and decision regret in #aya #hodgkinlymphoma survivors. There’s still time for patients to fill out the survey: bit.ly/3SLZ0ke

